首頁 > 市場調查報告書 > 工業機械

隔膜技術

市場調查報告書

商品編碼

1624380

全球製藥過濾市場規模：按產品、應用、技術、地區、範圍和預測

Global Pharmaceutical Filtration Market Size By Product (Membrane Filters, Filter Holders), By Application (Final Product Processing, Raw Material Filtration), By Technology (Microfiltration, Ultrafiltration), By Geographic Scope and Forecast

出版日期: 2024年10月13日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

醫藥過濾市場規模及預測

2024年醫藥過濾市場規模為266.9億美元，預計到2031年將達到552.1億美元，2024年至2031年複合年增長率為10.49%。藥品過濾是藥品生產的關鍵步驟。過濾液體和氣體，去除不需要的顆粒、微生物和其他污染物。考慮使用咖啡過濾器來防止咖啡渣進入咖啡杯。此方法保證了成品的純淨、安全，對病人有益。這些解決方案用於生產生物製劑，包括疫苗和單株抗體。這些產品經常容易受到污染，並且需要高純度。過濾有助於去除病毒和其他細菌，以確保生物製劑的安全性和有效性。過濾也用於製備藥物合成必需成分的原料和中間體。

它可能在未來的醫學中發揮重要作用。隨著製藥業的擴展和創新，有效的過濾方法變得越來越重要。過濾可確保藥物純度，這對於患者安全和治療效果至關重要。隨著個人化醫療變得越來越普遍，針對個別患者的治療方案需要更加精確，過濾方法也需要更加精確。

全球製藥過濾市場動態

塑造全球製藥過濾市場的主要市場動態

主要市場推動因素

藥品產量增加

由於全球對藥品的需求不斷增長，製藥業正在迅速擴張。隨著人口增長和老化，越來越多的人需要藥物來治療各種健康問題。藥品產量的增加需要使用有效且可靠的過濾技術。製藥公司正在提高生產能力以滿足這一需求，包括投資新的過濾技術以保持產品的純度和安全性。

嚴格的監理要求：

藥品必須符合美國FDA（食品藥物管理局）和歐洲EMA（歐洲藥品管理局）等機構制定的嚴格監管標準。這些法律確保藥品的安全性、有效性和品質。過濾是滿足這些標準的重要方面，因為它有助於去除藥物配方中的細菌、病毒、顆粒物和其他污染物。

過濾技術的進步

過濾技術的改進大大提高了藥品過濾的效率和效果。現代過濾系統提供更高的準確性、可擴展性和可靠性。薄膜過濾、深度過濾和奈米濾都是徹底改變該領域的技術創新的例子。

主要課題

確保無菌：

確保過濾器去除藥品中的所有細菌、病毒和其他病菌是一個重要問題。過濾器必須非常小，但足夠可靠，能夠捕獲最小的雜質。這非常重要，因為任何殘留的細菌都會使您生病或使您的藥物療效降低。製造商必須定期監控和測試過濾器，以確保它們正常工作，這既耗時又昂貴。

維護產品完整性：

過濾器必須去除污染物而不損壞藥物本身。有些過濾器會與藥物產生交互作用，改變其成分或降低其有效性。例如，一些化學過濾器可以去除或改變藥物中的活性成分。結果，最終產品的安全性和功效可能會受到損害。因此，選擇正確類型的過濾器來匹配特定的藥物很重要但很困難。

生產規模擴大：

從實驗室規模過渡到大規模製造需要仔細規劃。為了保持均勻性，過濾設備必須可擴展，流程必須標準化。因此，通常需要與工程專家合作來建立能夠在不犧牲品質的情況下管理更高容量的系統。通常會在全面生產之前進行中試，以確定潛在的問題。

主要趨勢：

先進的過濾技術

隨著製藥業的發展，過濾技術也不斷發展。深度過濾和薄膜過濾等傳統技術正在補充，在某些情況下被更現代的方法所取代。例如，一次性過濾裝置變得越來越普遍。

法規遵從性和品質保證：

由於藥品直接影響人類健康，FDA（美國食品藥物管理局）和EMA（歐洲藥品管理局）等監管機構制定了嚴格的標準，以確保產品的安全性和有效性。這一趨勢凸顯了在整個過濾過程中遵循這些要求的必要性。

永續性和環境影響：

隨著環境問題的增加，製藥業面臨減少對環境影響的壓力。這一趨勢正在推動更永續的過濾方法的開發和實施。例如，公司正在尋找透過使用可回收和可生物降解材料來減少過濾過程中產生的廢物的方法。

Merck KGaA（Germany）
Danaher Corporation（US）
Sartorius AG（Germany）
Thermo Fisher Scientific Inc.（US）
3M Company（US）
Eaton Corporation PLC（US）
Parker Hannifin Corporation（US）
Donaldson Company Inc.（US）
Alfa Laval Corporate AB（Sweden）
Repligen Corporation（US）
Porvair PLC（UK）
Corning Incorporated（US）
Meissner Filtration Products Inc.（US）

第11章市場前景與機遇

新興技術
未來市場趨勢
投資機會

第12章附錄

縮寫表
來源和參考文獻

簡介目錄

Product Code: 24093

Pharmaceutical Filtration Market Size And Forecast

Pharmaceutical Filtration Market size was valued at USD 26.69 Billion in 2024 and is projected to reach USD 55.21 Billion by 2031, growing at a CAGR of 10.49% from 2024 to 2031. Pharmaceutical filtration is an important step in the manufacture of pharmaceuticals. It entails passing liquid or gas through a filter to remove undesirable particles, microorganisms, and other contaminants. Consider using a coffee filter to keep coffee grounds out of your cup but on a much more intricate and exact level. This method assures that the finished product is pure, safe, and beneficial to patients. These solutions are used to manufacture biologics including vaccines and monoclonal antibodies. These items are frequently prone to contamination and require a high degree of purity. Filtration helps to remove viruses and other germs ensuring that biologics are safe and effective. Filtration is also used to prepare raw materials and intermediates both of which are necessary components in medication synthesis.

It is likely to play an important role in the future of medicine. As the pharmaceutical sector expands and innovates, effective filtration methods become increasingly crucial. Filtration ensures drug purity which is critical for patient safety and therapeutic efficacy. Filtration methods will need to be more accurate as customized medicine which tailors treatments to individual patients becomes more prevalent.

Global Pharmaceutical Filtration Market Dynamics

The key market dynamics that are shaping the global pharmaceutical filtration market include:

Key Market Drivers:

Increasing Drug Production

: The pharmaceutical sector is expanding fast in response to rising global demand for drugs. As populations increase and age, more people need drugs for a variety of health issues. This increase in medication production necessitates the use of effective and dependable filtration technologies. Pharmaceutical businesses are increasing their manufacturing capacity to satisfy this demand including investments in new filtration technologies to maintain product purity and safety.

Stringent Regulatory Requirements:

Pharmaceutical products must adhere to stringent regulatory criteria established by organizations such as the FDA (Food and Drug Administration) in the United States and the EMA (European Medicines Agency) in Europe. These laws ensure that pharmaceuticals are safe, effective, and high-quality. Filtration is an important aspect of meeting these criteria since it helps eliminate germs, viruses, particulate matter, and other contaminants from medicine formulations.

Advancements in Filtration Technology:

Filtering technology improvements have considerably improved the efficiency and effectiveness of pharmaceutical filtering. Modern filtering systems provide greater precision, scalability, and reliability. Membrane filtration, depth filtration, and nanofiltration are all examples of innovations that have transformed the sector.

Key Challenges:

Ensuring Sterility:

Ensure that filters eliminate all bacteria, viruses, and other germs from pharmaceutical items is a significant problem. Filters must be extremely tiny but yet dependable to capture even the smallest impurities. This is crucial since any lingering bacteria can lead to illnesses or diminish the medication's effectiveness. Manufacturers must regularly monitor and test the filters to ensure their correct operation which can be time-consuming and costly.

Maintaining Product Integrity:

Filters must eliminate pollutants without damaging the drug itself. Some filters may interact with the medications altering their composition or decreasing their effectiveness. For example, certain chemical filters may remove or change active components in the drug. This may jeopardize the safety and efficacy of the final product. As a result, selecting the appropriate type of filter that is compatible with the specific medicinal substance is critical but difficult.

Scaling Up Manufacturing:

The transition from lab-scale to full-scale manufacturing requires precise planning. To maintain uniformity, filtration equipment must be scalable and processes standardized. This frequently necessitates collaboration with engineering professionals to create systems that can manage higher quantities without sacrificing quality. Before full-scale production, pilot studies are frequently done to identify potential concerns.

Key Trends:

Advanced Filtration Technology

: As the pharmaceutical sector evolves, so does the technology utilized for filtration. Traditional technologies such as depth filtration and membrane filtration are being supplemented and in some cases replaced by more modern approaches. For example, single-use filtering devices are becoming more common.

Regulatory Compliance and Quality Assurance:

Pharmaceutical products have a direct impact on human health, hence regulatory authorities such as the FDA (Food and Drug Administration) and the EMA (European Medicines Agency) enforce tight criteria to assure product safety and efficacy. This trend highlights the need to follow these requirements throughout the filtration process.

Sustainability and Environmental Impact:

As environmental concerns develop, the pharmaceutical business faces pressure to lessen its environmental footprint. This trend is driving the development and implementation of more sustainable filtering practices. For example, companies are looking into ways to reduce trash generated during the filtration process by employing recyclable or biodegradable materials.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Pharmaceutical Filtration Market Regional Analysis

Here is a more detailed regional analysis of the global pharmaceutical filtration market:

North America:

The United States dominates the North American pharmaceutical filtration market, accounting for the majority of regional revenue and growth. Canada and Mexico also make substantial contributions to the market's growth. Several factors have contributed to the substantial expansion of North America's pharmaceutical filtering market. According to the United States Food and Medicine Administration (FDA), the number of new medicine approvals has gradually increased with 53 in 2020 and 50 in 2021. This trend suggests an increase in demand for pharmaceutical filtration goods and technology. According to the Centers for Disease Control and Prevention (CDC), chronic diseases cause seven out of ten fatalities in the United States each year necessitating the use of modern drugs.

The US Department of Health and Human Services invested more than $10 billion in Operation Warp Speed to facilitate speedy vaccine development and production. This endeavor enhanced the demand for filtering technologies in vaccine manufacturing processes. Furthermore, the National Institutes of Health (NIH) estimated a $41.7 billion budget for medical research in fiscal year 2020 with a substantial amount going toward drug discovery and development initiatives. The Canadian government recently pledged CAD 1 billion to the COVID-19 Response Fund which would help vaccine research and production efforts. These investments have strengthened the pharmaceutical filtration sector in North America.

Asia Pacific:

The Asia-Pacific region is predicted to be the fastest-growing pharmaceutical filtration market in the future years. This increase is primarily driven by the rapid expansion of the biopharmaceutical industry, rising healthcare spending, and rising demand for high-quality pharmaceutical products in countries such as China, India, and Japan.

The pharmaceutical sector in Asia Pacific has been rapidly expanding with a special emphasis on biopharmaceuticals. According to the International Trade Administration, China's pharmaceutical market was worth USD 134.4 Billion in 2018 and is expected to reach USD 161.8 Billion by 2023 expanding at a compound annual growth rate (CAGR) of 3.8%. Similarly, the Indian Brand Equity Foundation estimates that India's pharmaceutical business will be worth USD 100 Billion by 2025.

The pharmaceutical filtration industry is also growing as the region places a greater emphasis on quality control and regulatory compliance. According to the World Health Organization, countries in the Asia Pacific region are enacting stronger laws and quality standards for pharmaceutical manufacture. For example, China's National Medical Products Administration (NMPA) has been attempting to harmonize its regulatory system with international standards while India's Central Drugs Standard Control Organization (CDSCO) has increased control of pharmaceutical production processes.

Global Pharmaceutical Filtration Market: Segmentation Analysis

The Global Pharmaceutical Filtration Market is segmented based on Product, Application, Technology, and Geography.

Pharmaceutical Filtration Market, By Product

Membrane Filters
Filter Holders
Filtration Accessories
Others

Based on the Product, the Global Pharmaceutical Filtration Market is bifurcated into Membrane Filters, Filter Holders, Filtration Accessories, and Others. In the global pharmaceutical filtration market, membrane filters are the dominant product. Membrane filters are crucial for their high efficiency in removing contaminants such as bacteria, particulates, and unwanted proteins from pharmaceutical products. Their ability to provide sterile filtration is essential for ensuring the safety and efficacy of drugs. Additionally, membrane filters are versatile and used in various applications like sterilizing liquids and gases, and different stages of pharmaceutical production.

Pharmaceutical Filtration Market, By Application

Final Product Processing
Raw Material Filtration
Cell Separation
Water Purification
Air Filtration
Others

Based on Application, the Global Pharmaceutical Filtration Market is bifurcated into Final Product Processing, Raw Material Filtration, Cell Separation, Water Purification, Air Filtration, and Others. In the global pharmaceutical filtration market, final product processing stands out as dominant due to its critical role in ensuring the purity and safety of pharmaceutical products. Final product processing involves the filtration of finished medicines to remove contaminants and ensure compliance with regulatory standards. This stage is vital for maintaining product quality and efficacy directly impacting patient safety. Raw material filtration also holds significant importance ensuring that starting materials are free from impurities that could affect the final product. However, final product processing takes precedence due to its direct impact on the end-user and the stringent regulatory scrutiny applied to finished pharmaceuticals.

Pharmaceutical Filtration Market, By Technology

Microfiltration
Ultrafiltration
Nanofiltration
Reverse Osmosis
Others

Based on the Technology, the Global Pharmaceutical Filtration Market is bifurcated into Microfiltration, Ultrafiltration, Nanofiltration, Reverse Osmosis, and Others. In the global pharmaceutical filtration market, microfiltration stands out as a dominant technology. Microfiltration is widely preferred due to its versatility in removing particulate matter, bacteria, and other contaminants while allowing the passage of desirable molecules like proteins and enzymes. This capability is crucial in pharmaceutical manufacturing to ensure product purity and safety. Ultrafiltration follows closely, particularly in biopharmaceutical applications for its ability to separate and concentrate proteins and other biomolecules based on size.

Pharmaceutical Filtration Market, By Geography

North America
Europe
Asia Pacific
Rest of the World

Based on Geography, the Global Pharmaceutical Filtration Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. In the global pharmaceutical filtration market, North America is emerging as the dominant region. North America leads due to its advanced pharmaceutical manufacturing capabilities, stringent regulatory standards, and substantial investment in research and development. The region hosts several major pharmaceutical companies and has a robust infrastructure supporting innovative filtration technologies. In contrast, Asia Pacific and the Rest of the World regions show potential growth opportunities driven by increasing healthcare expenditure expanding pharmaceutical industries, and rising investments in infrastructure and technology. Overall, North America's dominance in the pharmaceutical filtration market is underpinned by its technological ability, regulatory adherence, and market maturity.

Key Players

The "Global Pharmaceutical Filtration Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
Merck KGaA, Danaher Corporation, Sartorius AG, Thermo Fisher Scientific, Inc., 3M Company, Eaton Corporation PLC, Parker Hannifin Corporation, Donaldson Company, Inc., Alfa Laval Corporate AB, Repligen Corporation, Porvair PLC, Corning Incorporated, Meissner Filtration Products, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Pharmaceutical Filtration Market Key Developments

In June 2024, Cytiva announced its Supor Prime sterilizing grade filters for high-concentration biologic pharmaceuticals to help medication producers increase yields, reduce blockages, and reduce costs.
In April 2024, Asahi Kasei introduced a membrane system for creating WFI (water for injection), a type of sterile water used in injection preparation. The membrane system was designed and developed using MicrozaTM hollow-fiber membrane for liquid product filtering and water purification.